332 related articles for article (PubMed ID: 34681023)
1. High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer Immunotherapy.
Quek C; Bai X; Long GV; Scolyer RA; Wilmott JS
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681023
[TBL] [Abstract][Full Text] [Related]
2. Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy.
Bai X; Quek C
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292642
[TBL] [Abstract][Full Text] [Related]
3. Single-cell melanoma transcriptomes depicting functional versatility and clinical implications of STIM1 in the tumor microenvironment.
Wong HS; Chang WC
Theranostics; 2021; 11(11):5092-5106. PubMed ID: 33859736
[No Abstract] [Full Text] [Related]
4. Single-cell RNA sequencing in melanoma: what have we learned so far?
Lim SY; Rizos H
EBioMedicine; 2024 Feb; 100():104969. PubMed ID: 38241976
[TBL] [Abstract][Full Text] [Related]
5. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
6. Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis.
Heinrich S; Craig AJ; Ma L; Heinrich B; Greten TF; Wang XW
J Hepatol; 2021 Mar; 74(3):700-715. PubMed ID: 33271159
[TBL] [Abstract][Full Text] [Related]
7. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
[TBL] [Abstract][Full Text] [Related]
8. Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma.
Fattore L; Ruggiero CF; Liguoro D; Mancini R; Ciliberto G
Cell Death Dis; 2019 Oct; 10(11):827. PubMed ID: 31672982
[TBL] [Abstract][Full Text] [Related]
9. Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy.
Gohil SH; Iorgulescu JB; Braun DA; Keskin DB; Livak KJ
Nat Rev Clin Oncol; 2021 Apr; 18(4):244-256. PubMed ID: 33277626
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues.
Ahmed R; Zaman T; Chowdhury F; Mraiche F; Tariq M; Ahmad IS; Hasan A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328458
[TBL] [Abstract][Full Text] [Related]
11. The current landscape of single-cell transcriptomics for cancer immunotherapy.
Guruprasad P; Lee YG; Kim KH; Ruella M
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601414
[TBL] [Abstract][Full Text] [Related]
12. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma.
Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X
Front Immunol; 2021; 12():758288. PubMed ID: 34804045
[TBL] [Abstract][Full Text] [Related]
14. The Genomic Landscape of Melanoma and Its Therapeutic Implications.
Yang TT; Yu S; Ke CK; Cheng ST
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239381
[TBL] [Abstract][Full Text] [Related]
15. The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma.
Zhou W; Xu X; Cen Y; Chen J
Front Immunol; 2022; 13():1085766. PubMed ID: 36601121
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics.
Olalekan S; Xie B; Back R; Eckart H; Basu A
Cell Rep; 2021 May; 35(8):109165. PubMed ID: 34038734
[TBL] [Abstract][Full Text] [Related]
17. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.
Pozniak J; Pedri D; Landeloos E; Van Herck Y; Antoranz A; Vanwynsberghe L; Nowosad A; Roda N; Makhzami S; Bervoets G; Maciel LF; Pulido-Vicuña CA; Pollaris L; Seurinck R; Zhao F; Flem-Karlsen K; Damsky W; Chen L; Karagianni D; Cinque S; Kint S; Vandereyken K; Rombaut B; Voet T; Vernaillen F; Annaert W; Lambrechts D; Boecxstaens V; Saeys Y; van den Oord J; Bosisio F; Karras P; Shain AH; Bosenberg M; Leucci E; Paschen A; Rambow F; Bechter O; Marine JC
Cell; 2024 Jan; 187(1):166-183.e25. PubMed ID: 38181739
[TBL] [Abstract][Full Text] [Related]
18. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
Bagaev A; Kotlov N; Nomie K; Svekolkin V; Gafurov A; Isaeva O; Osokin N; Kozlov I; Frenkel F; Gancharova O; Almog N; Tsiper M; Ataullakhanov R; Fowler N
Cancer Cell; 2021 Jun; 39(6):845-865.e7. PubMed ID: 34019806
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic technologies for immunotherapy studies on solid tumours.
Paterson K; Zanivan S; Glasspool R; Coffelt SB; Zagnoni M
Lab Chip; 2021 Jun; 21(12):2306-2329. PubMed ID: 34085677
[TBL] [Abstract][Full Text] [Related]
20. Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors.
Nirmal AJ; Regan T; Shih BB; Hume DA; Sims AH; Freeman TC
Cancer Immunol Res; 2018 Nov; 6(11):1388-1400. PubMed ID: 30266715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
